Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

Abstract

clinicaltrials.gov Identifier: NCT01295827.

Keywords

Affiliated Institutions

• Macquarie University AU
• Massachusetts General Hospital US
• Mayo Clinic US
• University of Pittsburgh US
• University of California, Los Angeles US
• South Texas Accelerated Research Therapeutics US
• Université Paris-Sud FR
• Institut Gustave Roussy FR
• Angeles Clinic and Research Institute US
• Mayo Clinic in Florida US
• Moffitt Cancer Center US
• Merck & Co., Inc., Rahway, NJ, USA (United States) US
• Dana-Farber Cancer Institute US
• The University of Texas MD Anderson Cancer Center US
• Westmead Hospital AU
• University of Pennsylvania US
• The University of Sydney AU
• University of California, San Francisco US
• Memorial Sloan Kettering Cancer Center US
• Princess Margaret Cancer Centre CA
• Melanoma Institute Australia AU
• WinnMed US

Related Publications